Screening, diagnosis and management of human cysticercosis and Taenia solium taeniasis: technical recommendations by the COHEMI project study group

The COHEMI Project Study Group

Producción científica: Artículo CientíficoArtículo originalrevisión exhaustiva

18 Citas (Scopus)

Resumen

Neurocysticercosis, the central nervous system's localised form of cysticercosis, is considered to be the leading cause of epilepsy in the developing world. In Europe, the disease is mainly imported and affects both immigrants and travellers. However, autochthonous cases of cysticercosis in low-endemic countries could also originate from Taenia solium carriers (migrants or travellers) who acquired taeniasis overseas. Management of cysticercosis is a challenge for European healthcare providers as they are often hardly aware of this infection and have little familiarity in managing this disease. This study provides a summary of recommendations concerning screening, diagnosis and management of cysticercosis and T. solium taeniasis in Europe drawn up by nine experts in migrant health and imported diseases with experience in cysticercosis and T. solium taeniasis.

Idioma originalInglés estadounidense
Páginas (desde-hasta)881-894
-14
PublicaciónTropical Medicine and International Health
Volumen22
N.º7
DOI
EstadoIndizado - 1 jul. 2017

Nota bibliográfica

Publisher Copyright:
© 2017 John Wiley & Sons Ltd

Huella

Profundice en los temas de investigación de 'Screening, diagnosis and management of human cysticercosis and Taenia solium taeniasis: technical recommendations by the COHEMI project study group'. En conjunto forman una huella única.

Citar esto